Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 12964
TargetHistone-lysine N-methyltransferase NSD2 [2-1365](Human)
K36 Therapeutics

US Patent
LigandPNGBDBM745483(US20250171454, Compound I-61)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2 [2-1365](Human)
K36 Therapeutics

US Patent
LigandPNGBDBM745486(US20250171454, Compound I-64)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2 [2-1365](Human)
K36 Therapeutics

US Patent
LigandPNGBDBM745487(US20250171454, Compound I-65)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2 [2-1365](Human)
K36 Therapeutics

US Patent
LigandPNGBDBM745488(US20250171454, Compound I-66)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2 [2-1365](Human)
K36 Therapeutics

US Patent
LigandPNGBDBM745489(US20250171454, Compound I-67)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2 [2-1365](Human)
K36 Therapeutics

US Patent
LigandPNGBDBM745493(US20250171454, Compound I-71)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2 [2-1365](Human)
K36 Therapeutics

US Patent
LigandPNGBDBM745491(US20250171454, Compound I-69)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2 [2-1365](Human)
K36 Therapeutics

US Patent
LigandPNGBDBM745484(US20250171454, Compound I-62)
Affinity DataIC50: 75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2 [2-1365](Human)
K36 Therapeutics

US Patent
LigandPNGBDBM745498(US20250171454, Compound 1-81)
Affinity DataIC50: 75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2 [2-1365](Human)
K36 Therapeutics

US Patent
LigandPNGBDBM745496(US20250171454, Compound I-79)
Affinity DataIC50: 550nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2 [2-1365](Human)
K36 Therapeutics

US Patent
LigandPNGBDBM745485(US20250171454, Compound I-63)
Affinity DataIC50: 550nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2 [2-1365](Human)
K36 Therapeutics

US Patent
LigandPNGBDBM745500(US20250171454, Compound I-84)
Affinity DataIC50: 550nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2 [2-1365](Human)
K36 Therapeutics

US Patent
LigandPNGBDBM745501(US20250171454, Compound I-85)
Affinity DataIC50: 550nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2 [2-1365](Human)
K36 Therapeutics

US Patent
LigandPNGBDBM745492(US20250171454, Compound I-70)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2 [2-1365](Human)
K36 Therapeutics

US Patent
LigandPNGBDBM745490(US20250171454, Compound I-68)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2 [2-1365](Human)
K36 Therapeutics

US Patent
LigandPNGBDBM745494(US20250171454, Compound I-76)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2 [2-1365](Human)
K36 Therapeutics

US Patent
LigandPNGBDBM745495(US20250171454, Compound I-77)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2 [2-1365](Human)
K36 Therapeutics

US Patent
LigandPNGBDBM745497(US20250171454, Compound I-80)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2 [2-1365](Human)
K36 Therapeutics

US Patent
LigandPNGBDBM745499(US20250171454, Compound I-82)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2 [2-1365](Human)
K36 Therapeutics

US Patent
LigandPNGBDBM745502(US20250171454, Compound SAH)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent